71
TITLE: Mechanically activated cholesteric polymer dispersed liquid crystals  Full Text
AUTHORS: Ferreira, AJ; Almeida, PL ; Costa, I; Brogueira, P ; Godinho, MH ;
PUBLISHED: 2007, SOURCE: LIQUID CRYSTALS, VOLUME: 34, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 1
72
TITLE: Presence of depressive symptoms in a group of subjects who accepted to participate in phase I studies in comparison with a control group.
AUTHORS: Luis Almeida; Benedita Azevedo; Manuel Vaz da Silva; Teresa Nunes; Amilcar Falcao; Rui Coelho; Antonio Albino Teixeira ; Patricio Soares da Silva ;
PUBLISHED: 2006, SOURCE: 35th Annual Meeting of the American-College-of-Clinical-Pharmacology in JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 46, ISSUE: 9
INDEXED IN: WOS
73
TITLE: Healthy subjects' motivations to volunteer for participation in human pharmacology studies.
AUTHORS: Luis Almeida; Benedita Azevedo; Teresa Nunes; Manuel Vaz da Silva; Antonio Albino Teixeira ; Amilcar Falcao; Rui Coelho; Patricio Soares da Silva ;
PUBLISHED: 2006, SOURCE: 35th Annual Meeting of the American-College-of-Clinical-Pharmacology in JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 46, ISSUE: 9
INDEXED IN: WOS
74
TITLE: State-anxiety and trait-anxiety in participants in phase I studies versus a control group.
AUTHORS: Benedita Azevedo; Luis Almeida; Manuel Vaz da Silva; Teresa Nunes; Amilcar Falcao; Rui Coelho; Antonio Albino Teixeira ; Patricio Soares da Silva ;
PUBLISHED: 2006, SOURCE: 25th Annual Meeting of the American-College-of-Clinical-Pharmacology in JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 46, ISSUE: 9
INDEXED IN: WOS
75
TITLE: Correlation between the personality trait-anxiety and the wilingness to volunteer for participation in phase I studies.
AUTHORS: Luis Almeida; Benedita Azevedo; Manuel Vaz da Silva; Teresa Nunes; Amilcar Falcao; Rui Coelho; Antonio Albino Teixeira ; Patricio Soares da Silva ;
PUBLISHED: 2006, SOURCE: 25th Annual Meeting of the American-College-of-Clinical-Pharmacology in JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 46, ISSUE: 9
INDEXED IN: WOS
76
TITLE: Steady-state pharmacokinetics of once-daily and twice-daily regimens of eslicarbazepine acetate (BIA 2-093) in healthy subjects
AUTHORS: Luis Almeida; Amilcar Falcao; Joana Maia; Manuel Vaz da Silva; Patricio Soares da Silva ;
PUBLISHED: 2006, SOURCE: 60th Annual Meeting of the American-Epilepsy-Society in EPILEPSIA, VOLUME: 47
INDEXED IN: WOS
77
TITLE: Effect of single-doses of nebicapone (BIA 3-202) on the catechol-O-methyltransferase (COMT) activity in healthy subjects
AUTHORS: Almeida, L; Falcao, A; Vaz da Silva, M; Wright, L; Torrao, L; Igreja, B; Soares, E; Maia, J; Nunes, T; Soares da Silva, P ;
PUBLISHED: 2006, SOURCE: 10th International Congress of Parkinson's Disease and Movement Disorders in MOVEMENT DISORDERS, VOLUME: 21
INDEXED IN: WOS
79
TITLE: Eslicarbazepine acetate (BIA 2-093): Relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200 mg and 800 mg tablet formulations
AUTHORS: Nunes, T; Falcao, A; Almeida, L; Lima, R; Tavares, S; Neta, C; Fontes Ribeiro, C; Macedo, T; Soares da Silva, P ;
PUBLISHED: 2005, SOURCE: 26th International Epilepsy Congress in EPILEPSIA, VOLUME: 46
INDEXED IN: WOS
80
TITLE: Relative bioavailability and bioequivalence of three different oral formulations of eslicarbazepine acetate
AUTHORS: Nunes, T; Falcao, A; Almeida, L; Lima, R; Tavares, S; Neta, C; Fontes Ribeiro, C; Macedo, T; Soares da Silva, P ;
PUBLISHED: 2005, SOURCE: Joint Annual Meeting of the American-Epilepsy-Society/American-Clinical-Neurophsiology-Society in EPILEPSIA, VOLUME: 46
INDEXED IN: WOS
Page 8 of 10. Total results: 94.